Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    July 2018
  1. KNODLER M, Korfer J, Kunzmann V, Trojan J, et al
    Randomised phase II trial to investigate catumaxomab (anti-EpCAM x anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer.
    Br J Cancer. 2018 Jul 10. pii: 10.1038/s41416-018-0150.
    PubMed     Text format     Abstract available


    March 2018
  2. XIN L, Yang WF, Zhang HT, Li YF, et al
    The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin.
    Br J Cancer. 2018 Mar 26. pii: 10.1038/s41416-018-0043.
    PubMed     Text format     Abstract available


  3. SHIMADA S, Akiyama Y, Mogushi K, Ishigami-Yuasa M, et al
    Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
    Br J Cancer. 2018 Mar 12. pii: 10.1038/s41416-018-0008.
    PubMed     Text format     Abstract available


    February 2018
  4. MIKI Y, Yashiro M, Okuno T, Kitayama K, et al
    CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells.
    Br J Cancer. 2018 Feb 13. pii: bjc2017487. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    December 2017
  5. WANG X, Zhao DB, Yang L, Chi Y, et al
    S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study.
    Br J Cancer. 2017 Dec 12. pii: bjc2017424. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    November 2017
  6. FANG C, Wang W, Feng X, Sun J, et al
    Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Br J Cancer. 2017;117:1544-1550.
    PubMed     Text format     Abstract available


    October 2017
  7. SEO AN, Kang BW, Kwon OK, Park KB, et al
    Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.
    Br J Cancer. 2017 Oct 26. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    September 2017
  8. GAYARRE J, Martin-Gimeno P, Osorio A, Paumard B, et al
    Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.
    Br J Cancer. 2017;117:1048-1062.
    PubMed     Text format     Abstract available


  9. ALMEIDA GS, Panek R, Hallsworth A, Webber H, et al
    Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform.
    Br J Cancer. 2017;117:791-800.
    PubMed     Text format     Abstract available


    August 2017
  10. JIMENEZ FONSECA P, Carmona-Bayonas A, Hernandez R, Custodio A, et al
    Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
    Br J Cancer. 2017 Aug 1. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    June 2017
  11. SAMARENDRA H, Jones K, Petrinic T, Silva MA, et al
    A meta-analysis of CXCL12 expression for cancer prognosis.
    Br J Cancer. 2017;117:124-135.
    PubMed     Text format     Abstract available


  12. KUROKAWA Y, Yang HK, Cho H, Ryu MH, et al
    Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.
    Br J Cancer. 2017;117:25-32.
    PubMed     Text format     Abstract available


  13. SIERZEGA M, Kaczor M, Kolodziejczyk P, Kulig J, et al
    Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331.
    Br J Cancer. 2017 Jun 22. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  14. ZHANG P, Tang WM, Zhang H, Li YQ, et al
    MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
    Br J Cancer. 2017 Jun 20. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  15. CUSTODIO A, Carmona-Bayonas A, Jimenez-Fonseca P, Sanchez ML, et al
    Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.
    Br J Cancer. 2017;116:1526-1535.
    PubMed     Text format     Abstract available


    April 2017
  16. WENNERSTROM ECM, Simonsen J, Camargo MC, Rabkin CS, et al
    Acid-suppressing therapies and subsite-specific risk of stomach cancer.
    Br J Cancer. 2017;116:1234-1238.
    PubMed     Text format     Abstract available


    March 2017
  17. PETRICK JL, Kelly SP, Liao LM, Freedman ND, et al
    Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
    Br J Cancer. 2017;116:951-959.
    PubMed     Text format     Abstract available


  18. BAI T, Yokobori T, Altan B, Ide M, et al
    High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Br J Cancer. 2017 Mar 23. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  19. SONG Y, Wang Y, Tong C, Xi H, et al
    A unified model of the hierarchical and stochastic theories of gastric cancer.
    Br J Cancer. 2017 Mar 16. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    February 2017
  20. WANG Z, Koh WP, Jin A, Wang R, et al
    Composite protective lifestyle factors and risk of developing gastric adenocarcinoma: the Singapore Chinese Health Study.
    Br J Cancer. 2017;116:679-687.
    PubMed     Text format     Abstract available


  21. LIANG X, Shi H, Yang L, Qiu C, et al
    Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
    Br J Cancer. 2017 Feb 21. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    January 2017
  22. LI P, Chen H, Chen S, Mo X, et al
    Circular RNA 0000096 affects cell growth and migration in gastric cancer.
    Br J Cancer. 2017 Jan 12. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    December 2016
  23. KODAMA H, Murata S, Ishida M, Yamamoto H, et al
    Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Br J Cancer. 2016 Dec 8. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    November 2016
  24. OHASHI T, Komatsu S, Ichikawa D, Miyamae M, et al
    Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Br J Cancer. 2016 Nov 29. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: